{"name":"Forward Pharmaceuticals Co., Ltd.","slug":"forward-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"forward.com","description":"Forward Pharmaceuticals Co., Ltd. is a biotechnology company focused on the development of novel therapies for metabolic and liver diseases. The company's lead candidates are in early-stage clinical trials, with a focus on advancing treatments that address significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FWD1802","genericName":"FWD1802","slug":"fwd1802","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"FWD1802","genericName":"FWD1802","slug":"fwd1802","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNUjNTdUd4QnBqQUVPdUxCNlBpclVfYmpRY0lmb2tYbUJpM1JtUUtRMkJ0R0sybmpKMHl4UjV4UktRcTIzamxQTnRkcDQwYmJhWUhnVU5QY3R5MTBNS1VHY2xaRmN4aHVudEhDQXAwX0FCQjhvZzExMkI5Q0VkdmpFckttYw?oc=5","date":"2026-03-31","type":"deal","source":"StocksToTrade","summary":"BullFrog AI Leaps Forward with Major Pharma Deal - StocksToTrade","headline":"BullFrog AI Leaps Forward with Major Pharma Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNNUNaMXhJclVvQVJFYThpc21aWHJ5c1FzaHpEcnA1bUpmNXZDb1RUV013ZDFtVG5EaGgyNkx4OEhaQjhqLUFXT09MUXJWaE1HWkdmRlpRZGRzdlMxajRpemlnSUg5aEtoU2NQTUt1Y1dETVBOY2x1Z05Oc3prTjFhRm9IR2tfUlNIWHlFSkdkTkpNbk9FNzFMdHlZVGtsNGc?oc=5","date":"2026-02-03","type":"pipeline","source":"statnews.com","summary":"Pfizer moves forward with its hopes for a monthly obesity drug - statnews.com","headline":"Pfizer moves forward with its hopes for a monthly obesity drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPd202MnprTE1EeFhNNGFab08wTUtGWF9QMnlUV0ZKbTItMXZwQ3pXT2NVc0UzMnVvclZtRF9BTTZGNHZlWUFnV05JR2tnSlRuMDVEcUNkWU9rTENLN3BEa095X19mUUZ4NjZqbHRzdWJvSGlZZmpwTmUtQmx0ZEVFZ1cwb2xJVzl1NV9oY19tMm9iZERJZUlid2JTOElLd0NKWEstdlRHcUVqMmVQOHhjRjJoZG9aSmVjWkxReVIxbHoyT3RsVzZKMWRzMjFoU2pvSThhRzVlRDFQSGFsMS1UOGtzSnFIbXM5NzlmRFhEdGIwaTV2LURkV3ZIVTRPNlh1bmNkMXhUTjltcWtPOE5MdmZFVkx4YjBU?oc=5","date":"2026-01-29","type":"regulatory","source":"BioSpace","summary":"LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES - BioSpace","headline":"LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE04UTlJYjBMZ09keXEwQ2tnNmwzLTh4ejlNZ1d6bjByV1lIVzV1QXpid1FyWk5oTnoxQ2k2TzhNSE9TeXBoVFF3VTJnQS1RWjhIbUhicV9RN0xETVZja3EtQjJn?oc=5","date":"2026-01-29","type":"pipeline","source":"akesobio.com","summary":"Ivonescimab Included in FirstWord Pharma's \"The Drugs That Will Shape 2026\" - akesobio.com","headline":"Ivonescimab Included in FirstWord Pharma's \"The Drugs That Will Shape 2026\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOalppcll5MXRsNG1TMV9xRUlSR0RTQTRBSlRSQlRJVjR4U2NzM3FULUtpcFFYRGhHTFZxaG4zclI3UWtUcVBqWGdaa0g0RTNFaGpzb2Jwcy1LaTdWME9vUmtqV01EMDRnOU5lZTFIM1Vocm81cTE2VXJRMGV5Y1FVMkRmLUd5NHRpbWpHTVdxcktkeHpyZDctTzlTckk4cUNjUFFwVGlZUlNjdFBOQnhwUTFFRGtCVkYyckFDQ2N5OA?oc=5","date":"2025-12-23","type":"trial","source":"Stock Titan","summary":"Early PH-762 skin cancer trial sees full tumor clearance in some patients - Stock Titan","headline":"Early PH-762 skin cancer trial sees full tumor clearance in some patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNcG1IcVpOVExYUG1XSVNJaGFNNzJVcXFoWVJKMDFTaHBJNi1DX2dxOE80azlSUHdtRHIzNTZ6dXhEUXFDcl9HVGYxRWZpekVTY1MtVXRqV2lkb2l5bEFWZlQzbE5lT2pSY3BDaU1nQkllOEZ1Snk3Q3lnb1dPRzdPWkR6ZFVKLW1YUWZsZHgxS2ZMa0JybXBmcXlOdXRfTThuX0JwMkhBVGhhTU1lNEVwODBjM1pQQjRKb2NBeXl4V1pVZEI4NW1URVNlajQ5ZVZKcWtEb3o1eVgtdkh3TXhSTFhScEpZaGlUdUhtR09zU2JFY0Q3VllKa00ySXRqMVV4WlJEN0tQbmtKalp6U2dCaEpxblhJYzJTVDEwTXU0OXNWNWxQbXJ5Wk5XRk9jY3FqY3EyaElUdUI?oc=5","date":"2025-11-06","type":"patent","source":"Finansavisen","summary":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - Finansavisen","headline":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNRjJCNUx3VHkyUTJ4WmhQNnVFMXJVdjBRSEc5bEY2NFN5aU1GclpJRmdtR0tzeWtvc0Z2bGZZcnhUUmk2Rl8xcUY5Z0V4LVdNZnZ6cTQ2RWV2ZDA5eTBOaG5QQXYxMk5zYktlbTRTbXVtdUdvdDV3M0tSbnJSY0l1RzA1am5iNG83d3hIWnlGaWRjWDVBS2dqUnRHZDdKZHptT01FSjVLZS1CcVBITlRhOFhlSVQ0Zw?oc=5","date":"2025-07-30","type":"pipeline","source":"Fierce Pharma","summary":"Teva execs shrug off pharmaceutical tariff threat as turnaround strategy rolls forward - Fierce Pharma","headline":"Teva execs shrug off pharmaceutical tariff threat as turnaround strategy rolls forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPc2g0MFFBZk9IVjg5OG1mdy1xODN3dlBVdjRPZGctN2x0b1Zta3Q3Xy1HVFBURmN0TkpkVnFFSFdVbXhhR3F5WGVWUi1XeE45RFAweUsxaTdlN1hJbVdSYjJEb3RKOWw4QTF3SlFtaVF0WVRuSHlscW1WRGVEZXJhaW8tVnhWUQ?oc=5","date":"2025-06-13","type":"pipeline","source":"JAPAN Forward","summary":"Japan's Oldest Pharma Firm to Be Sold to Bain Capital - JAPAN Forward","headline":"Japan's Oldest Pharma Firm to Be Sold to Bain Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"PR Newswire","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - PR Newswire","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBBUWZJamNXQlZfUjVXaDEwX0Y5NFlfM0JFZFUtOVdUNlhCRmNMcE9aSVg0TVVlN0tVcWJBZXBnTW1zQldOZGlTZ3hGV3hTVENrSnRxMnJWbS1SdWs3bFNTcnh5SzE?oc=5","date":"2024-10-01","type":"pipeline","source":"ono-pharma.com","summary":"STORY02 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH\" | About | ONO PHARMACEUTICAL CO., LTD. - ono-pharma.com","headline":"STORY02 | ONO Pharmaceutical’s corporate slogan: BREAK THROUGH\" | About | ONO PHARMACEUTICAL CO., LTD. - ono","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE0wUjhmaFo5a2t0N1ltMVJWVUxUZmtGT21nR2w5ZXRGUXBWV0JiWmx0dnpfUDNZTGpPUkwtMkwyREZLMmI0a2ZGOC0xUHhPN210WVJXdTk2aGNjNHp3Wk4wd3hFVjJDWFBuX1RHYlExUGJOa2hERllzTDltYnl4QQ?oc=5","date":"2023-01-12","type":"pipeline","source":"Labiotech.eu","summary":"Biotech in Asia: looking forward to 2023 - Labiotech.eu","headline":"Biotech in Asia: looking forward to 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWXl5UlNXVFNmWEhGcWhQZ2lBaFZmcWVhRXVNRVF0VlZJVVBnYUswTXE0YmotdEd6cVpwYjd2VlNTVS1XalZ6b2dXRG9VWXV2S294aGdoa0taVW9zVmxCMHg1NXM1Nnh6aEtMTWExazJNUG9DM21abnRYT3NyUnNmTVotX2NnWU96bUQ1M0hqSVE4R2UwZThiMGpRdEdOakpTZ1BTRHA2MFQzTEhOelZiSUp6U1BfVE1CYWduVzNpc0JrZw?oc=5","date":"2017-01-17","type":"deal","source":"Biogen","summary":"Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement - Biogen","headline":"Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}